Leslie Erin Gilbert, MD
Fax: (864) 455-5164
About us
Leslie Gilbert, MD MSCI joined the pediatric hematology oncology group at Prisma Health-Upstate in 2015 after completing her pediatric residency at Levine Children's Hospital in Charlotte, NC and her pediatric hematology oncology fellowship at Vanderbilt University Medical Center in Nashville, TN. She also completed a Masters of Science in Clinical Investigation at Vanderbilt University. She is board certified in general pediatrics and in pediatric hematology oncology. In addition to taking care of pediatric patients with oncology diagnoses, she has a special interest in bleeding disorders and vascular malformations. She serves as the Medical Director of the South Carolina Hemophilia Treatment Center - Upstate.
| Tags | sturge weber syndrome, generalized lymphatic anomaly, infantile hemangioma, kaposiform hemangioendothelioma, lymphatic malformation, vascular malformation, port wine stain, overgrowth syndrome, kaposiform lymphangiomatosis, hemangiomas, phace syndrome, burkitt lymphoma, cloves syndrome, kasabach merritt phenomenon (kmp), venous occlusive crisis, diffuse intrinsic pontine glioma (dipg), glucose 6 phosphate dehydrogenase deficiency, hereditary spherocytosis, histiocytosis, bone sarcoma, cancer survivor, optic pathway glioma, pulmonary metastases, sacrococcygeal teratoma, breast cancer immunotherapy, adverse effects to anticoagulants, anemia, anemia of chronic disease, antithrombin deficiency, aplastic anemia, b12 deficiency anemia, blood cancer, blood disorders, bone marrow disorders, cooley anemia, cryoglobulinemia, bleeding disorder, familial aplastic anemia, hemolytic anemia, hemophilia, heparin induced thrombocytopenia, hypogammaglobulinemia, idiopathic thrombocytopenic purpura, iron deficiency anemia, langerhans cell histiocytosis, leukopenia, lymphopenia, myeloproliferative diseases, neutropenia, paroxysmal nocturnal hemoglobinuria, petechiae, polycythemia, porphyria, pure red cell aplasia, purpura, rh incompatibility, secondary polycythemia, sickle cell disease, splenomegaly, thalassemia, thrombocytopenia, thrombocytosis, thrombophilia, von willebrand disease, pancytopenia, acute myelogenous leukemia (aml), hemolytic uremic syndrome, lymphoma, non hodgkin lymphoma, diamond blackfan anemia, dyskeratosis congenita, factor eight disorder, factor nine deficiency, peutz jeghers syndrome, plasma cell dyscrasia, pleomorphic xanthoastrocytomas, teratogen exposure, pediatric cancer, blood clotting disorder, factor v leiden, hemochromatosis, myelodysplastic syndrome, primary systemic amyloidosis, adjuvant chemotherapy, anaplastic cancer of thyroid, biological targeted therapy, cancer chemotherapy, cancer genomics, chemoradiation, early detection of cancer, epithelioid hemangioendothelioma, cancer immunotherapy, li fraumeni syndrome, acute lymphoblastic leukemia (all), fanconi anemia, hemolytic disease of the fetus, hypercoagulable state, leukemia, pernicious anemia, severe congenital neutropenia |